The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114322745 11432274 5 F 2014 20160906 20150828 20160913 PER US-PFIZER INC-2015277322 PFIZER 69.00 YR M Y 67.00000 KG 20160913 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114322745 11432274 1 PS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY 21446 150 MG CAPSULE, HARD BID
114322745 11432274 2 SS LYRICA PREGABALIN 1 Oral 75 MG, 2X/DAY 21446 75 MG CAPSULE, HARD BID
114322745 11432274 3 SS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY 21446 150 MG CAPSULE, HARD BID
114322745 11432274 4 SS LYRICA PREGABALIN 1 Oral 225 MG, 2X/DAY (ONCE IN THE MORNING AND ONCE IN THE EVENING) 21446 225 MG CAPSULE, HARD BID
114322745 11432274 5 SS LYRICA PREGABALIN 1 150 MG, 2X/DAY L91501 21446 150 MG CAPSULE, HARD BID
114322745 11432274 6 SS LYRICA PREGABALIN 1 100 MG, UNK 21446 100 MG CAPSULE, HARD
114322745 11432274 7 C TRAMADOL. TRAMADOL 1 Oral 100 MG, 2X/DAY 0 100 MG TABLET BID
114322745 11432274 8 C TRAMADOL. TRAMADOL 1 Oral 200 MG, DAILY 0 200 MG TABLET
114322745 11432274 9 C TRAMADOL. TRAMADOL 1 0 TABLET
114322745 11432274 10 C ALPRAZOLAM. ALPRAZOLAM 1 Oral 0.25 MG, 2X/DAY 0 .25 MG TABLET BID
114322745 11432274 11 C LANTUS INSULIN GLARGINE 1 Subcutaneous 15 IU, 1X/DAY IN THE MID AFTERNOON 0 15 IU INJECTION QD
114322745 11432274 12 C LANTUS INSULIN GLARGINE 1 Subcutaneous 0.1 ML, 1X/DAY 0 .1 ML INJECTION QD
114322745 11432274 13 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 500 MG, 2X/DAY 0 500 MG TABLET BID
114322745 11432274 14 C METFORMIN METFORMIN HYDROCHLORIDE 1 0 TABLET
114322745 11432274 15 C XANAX ALPRAZOLAM 1 Oral 0.25 MG, 2X/DAY AS NEEDED 0 .25 MG TABLET BID
114322745 11432274 16 C XANAX ALPRAZOLAM 1 0 TABLET
114322745 11432274 17 C DOCQLACE DOCUSATE SODIUM 1 Oral 100 MG, 2X/DAY AS NEEDED 0 100 MG CAPSULE BID
114322745 11432274 18 C FLONASE FLUTICASONE PROPIONATE 1 Nasal UNK, DAILY (50 MCG/ACTUATION/ 1 SPRAY BY EACH NOSTRIL ROUTE ONCE DAILY) 0 NASAL SPRAY
114322745 11432274 19 C ISOPROPYL ALCOHOL. ISOPROPYL ALCOHOL 1 UNK, DAILY (1 EACH BY MISCELLANEOUS ROUTE DAILY EVERY NIGHT) 0
114322745 11432274 20 C MELATONIN MELATONIN 1 Oral 1 MG, DAILY (TAKE 1 TABLET / EVERY NIGHT) 0 1 MG TABLET
114322745 11432274 21 C MOBIC MELOXICAM 1 Oral 15 MG, 1X/DAY 0 15 MG TABLET QD
114322745 11432274 22 C ULTRAM TRAMADOL HYDROCHLORIDE 1 Oral 50 MG, 2X/DAY 0 50 MG TABLET BID
114322745 11432274 23 C DULCOLAX NOS BISACODYL OR DOCUSATE SODIUM 1 Oral 100 MG, 1X/DAY 0 100 MG CAPSULE, SOFT QD
114322745 11432274 24 C ACETAMINOPHEN AND CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 Oral UNK, 2X/DAY (CODEINE PHOSPHATE 30MG, PARACETAMOL) (ONCE ON MORNING AND ONCE IN LATE AFTERNOON) 0 TABLET BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114322745 11432274 1 Diabetic neuropathy
114322745 11432274 2 Rheumatoid arthritis
114322745 11432274 3 Osteoarthritis
114322745 11432274 4 Neuropathy peripheral
114322745 11432274 7 Pain
114322745 11432274 8 Diabetic nephropathy
114322745 11432274 9 Neuropathy peripheral
114322745 11432274 10 Anxiety
114322745 11432274 11 Type 2 diabetes mellitus
114322745 11432274 13 Type 2 diabetes mellitus
114322745 11432274 14 Supplementation therapy
114322745 11432274 15 Sleep disorder
114322745 11432274 16 Anxiety
114322745 11432274 17 Constipation
114322745 11432274 22 Pain
114322745 11432274 23 Abnormal faeces
114322745 11432274 24 Neuralgia

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
114322745 11432274 Activities of daily living impaired
114322745 11432274 Burning sensation
114322745 11432274 Condition aggravated
114322745 11432274 Diabetic neuropathy
114322745 11432274 Drug ineffective
114322745 11432274 Expired product administered
114322745 11432274 Intentional product misuse
114322745 11432274 Pain
114322745 11432274 Peripheral swelling
114322745 11432274 Tenderness
114322745 11432274 Vibratory sense increased
114322745 11432274 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114322745 11432274 2 20151209 0
114322745 11432274 3 20160107 0
114322745 11432274 12 20150323 0
114322745 11432274 15 20160204 0
114322745 11432274 17 20141004 0
114322745 11432274 18 20160104 0
114322745 11432274 19 20150323 0
114322745 11432274 20 20150304 0
114322745 11432274 21 20151019 0
114322745 11432274 22 20151224 0